Annexon, Inc.
US ˙ NasdaqGS ˙ US03589W1027

Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Jung Choi. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Jung Choi reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
US:ANNX / Annexon, Inc. Director 33,000
US:GBT / Global Blood Therapeutics Inc. See Remarks 0
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Jung Choi. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Compras Internas ANNX / Annexon, Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em ANNX / Annexon, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
2025-12-01 ANNX Choi Jung 33,000 4.1900 33,000 4.1900 138,270 52 6.9600 91,410 66.11

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

ANNX / Annexon, Inc. Insider Trades
Vendas Internas ANNX / Annexon, Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em ANNX / Annexon, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

ANNX / Annexon, Inc. Insider Trades
Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Jung Choi conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual
Preço
da Ação
Valor
da Transação
Valor
Restante
2025-12-03 2025-12-01 4 ANNX Annexon, Inc.
Common Stock
P - Purchase 33,000 33,000 4.19 138,270 138,270
2022-10-06 2022-10-05 4 GBT Global Blood Therapeutics, Inc.
Common Stock
D - Sale to Issuer -25,000 0 -100.00
2022-10-06 2022-10-05 4 GBT Global Blood Therapeutics, Inc.
Common Stock
D - Sale to Issuer -226,672 0 -100.00
2022-09-29 2022-09-29 4 GBT Global Blood Therapeutics, Inc.
Common Stock
G - Gift -73,855 226,672 -24.58
2022-09-29 2022-09-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,674 300,527 0.90 3.40 9,092 1,021,792
2022-09-29 2022-09-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,674 300,527 0.90 3.40 9,092 1,021,792
2022-09-29 2022-09-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 74,964 295,179 34.04 3.40 254,878 1,003,609
2022-09-29 2022-09-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,275 220,215 1.04 65.82 149,740 14,494,551
2022-09-29 2022-09-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 16,902 217,940 8.41 16.40 277,193 3,574,216
2022-09-06 2022-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -1,861 201,038 -0.92 68.15 -126,827 13,700,740
2022-09-06 2022-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,208 202,899 1.10
2022-09-06 2022-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,763 200,691 1.40
2022-08-03 2022-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -2,126 197,928 -1.06 32.40 -68,882 6,412,867
2022-08-03 2022-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 6,145 200,054 3.17
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to buy)
A - Award 28,628 28,628
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 17,668 17,668
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 17,668 17,668
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,763 16,577 -14.29
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -956 191,374 -0.50 29.87 -28,556 5,716,341
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,763 192,330 1.46
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,020 12,080 -20.00
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,125 6,250 -33.33
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,875 0 -100.00
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3,340 189,567 -1.73 29.33 -97,962 5,560,000
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 9,020 192,907 4.91
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,020 15,100 -16.67
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,125 9,375 -25.00
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,875 2,875 -50.00
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3,743 182,367 -2.01 27.33 -102,296 4,984,090
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 9,020 186,110 5.09
2021-09-03 2021-09-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,762 19,340 -12.50
2021-09-03 2021-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -1,370 183,887 -0.74 29.85 -40,894 5,489,027
2021-09-03 2021-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,762 185,257 1.51
2021-09-03 2021-08-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 128 182,495 0.07 24.39 3,122 4,451,053
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,020 15,100 -16.67
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,125 9,375 -25.00
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,875 2,875 -50.00
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3,743 182,367 -2.01 27.33 -102,296 4,984,090
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 9,020 186,110 5.09
2021-06-04 2021-06-02 4 ANNX Annexon, Inc.
Stock Option (Right to Buy)
A - Award 10,000 10,000
2021-03-03 2021-03-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 22,102 22,102
2021-03-03 2021-03-01 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 38,739 38,739
2021-03-03 2021-02-28 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 140 177,090 0.08 36.21 5,069 6,412,429
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,020 18,120 -14.29
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,125 12,500 -20.00
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,875 5,750 -33.33
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4,063 0 -100.00
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -4,646 176,950 -2.56 49.49 -229,931 8,757,256
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 13,083 181,596 7.76
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,020 21,140 -12.50
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,125 15,625 -16.67
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,875 8,625 -25.00
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4,062 4,063 -49.99
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -6,239 168,513 -3.57 67.48 -421,008 11,371,257
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 13,082 174,752 8.09
2020-08-04 2020-07-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 162 161,670 0.10 36.68 5,942 5,930,056
2020-06-03 2020-06-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 42,400 42,400
2020-02-04 2020-02-03 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 38,500 38,500
2020-02-04 2020-02-03 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 24,160 24,160
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,125 18,750 -14.29
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,875 11,500 -20.00
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4,063 8,125 -33.34
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3,570 161,508 -2.16 65.26 -232,978 10,540,012
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 10,063 165,078 6.49
2020-02-04 2020-01-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 286 155,015 0.18 36.68 10,490 5,685,950
2019-12-17 2019-12-13 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -5,000 0 -100.00
2019-12-17 2019-12-13 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -2,479 154,729 -1.58 76.88 -190,586 11,895,566
2019-12-17 2019-12-13 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 5,000 157,208 3.28
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -3,125 21,875 -12.50
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,875 14,375 -16.67
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4,062 12,188 -25.00
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3,990 152,208 -2.55 54.25 -216,458 8,257,284
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 10,062 156,198 6.89
2019-08-05 2019-07-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 285 146,136 0.20 36.68 10,454 5,360,268
2019-04-10 2019-04-08 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,000 5,000 -28.57
2019-04-10 2019-04-08 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -692 145,851 -0.47 58.51 -40,489 8,533,742
2019-04-10 2019-04-08 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,000 146,543 1.38
2019-04-10 2019-01-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 269 144,543 0.19 36.68 9,867 5,301,837
2019-02-14 2018-07-31 5 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 277 144,274 0.19 35.53 9,842 5,126,055
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,875 17,250 -14.29
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4,063 16,250 -20.00
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 25,000 25,000
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 40,000 40,000
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -2,515 143,997 -1.72 48.44 -121,827 6,975,215
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 6,938 146,512 4.97
2018-08-03 2018-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,875 20,125 -12.50
2018-08-03 2018-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4,062 20,313 -16.66
2018-08-03 2018-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -3,440 139,574 -2.41 43.15 -148,436 6,022,618
2018-08-03 2018-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 6,937 143,014 5.10
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 2,675 -18.35
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 2,675 -18.35
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -198 74,964 -0.26
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 136,077 -1.02 48.25 -67,550 6,565,715
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 137,477 0.44 3.40 2,043 467,422
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 137,477 0.44 3.40 2,043 467,422
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 136,275 0.15 3.40 673 463,335
2018-05-21 2018-05-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 136,077 -1.16 48.25 -77,200 6,565,715
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 3,276 -15.50
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 3,276 -15.50
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -198 75,162 -0.26
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 137,677 -1.01 45.50 -63,700 6,264,304
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 139,077 0.43 3.40 2,043 472,862
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 139,077 0.43 3.40 2,043 472,862
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 137,875 0.14 3.40 673 468,775
2018-04-19 2018-04-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 137,677 -1.15 45.50 -72,800 6,264,304
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 3,877 -13.42
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 3,877 -13.42
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -198 75,360 -0.26
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 139,277 -1.00 54.15 -75,810 7,541,850
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 140,677 0.43 3.40 2,043 478,302
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 140,677 0.43 3.40 2,043 478,302
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 139,475 0.14 3.40 673 474,215
2018-03-20 2018-03-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 139,277 -1.14 54.15 -86,640 7,541,850
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 4,478 -11.83
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -601 4,478 -11.83
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -198 75,558 -0.26
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 140,877 -0.98 62.95 -88,130 8,868,207
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 142,277 0.42 3.40 2,043 483,742
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 142,277 0.42 3.40 2,043 483,742
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 141,075 0.14 3.40 673 479,655
2018-02-21 2018-02-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 140,877 -1.12 62.95 -100,720 8,868,207
2018-02-16 2018-02-14 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,000 7,000 -22.22
2018-02-16 2018-02-14 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -692 142,477 -0.48 62.30 -43,112 8,876,317
2018-02-16 2018-02-14 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,000 143,169 1.42
2018-02-14 2017-07-31 5 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 676 135,931 0.50 13.69 9,254 1,860,895
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 23,000 23,000
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 35,000 35,000
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4,063 24,375 -14.29
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -1,405 140,058 -0.99 59.60 -83,738 8,347,457
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 4,063 141,463 2.96
2018-02-02 2018-01-31 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,000 9,000 -18.18
2018-02-02 2018-01-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -692 137,400 -0.50 57.90 -40,067 7,955,460
2018-02-02 2018-01-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,000 138,092 1.47
2018-01-26 2018-01-24 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,000 11,000 -15.38
2018-01-26 2018-01-24 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -686 136,092 -0.50 58.15 -39,891 7,913,750
2018-01-26 2018-01-24 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,000 136,778 1.48
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -601 5,079 -10.58
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -601 5,079 -10.58
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -198 75,756 -0.26
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 134,778 -1.17 52.85 -84,560 7,123,017
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 136,378 -1.02 52.85 -73,990 7,207,577
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 137,778 0.44 3.40 2,043 468,445
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 137,778 0.44 3.40 2,043 468,445
2018-01-18 2018-01-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 136,576 0.15 3.40 673 464,358
2018-01-18 2018-01-16 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -2,000 13,000 -13.33
2018-01-18 2018-01-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -877 136,378 -0.64 52.10 -45,692 7,105,294
2018-01-18 2018-01-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 2,000 137,255 1.48
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 5,680 -9.57
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 5,680 -9.57
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -198 75,954 -0.26
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 135,255 -1.02 36.55 -51,170 4,943,570
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 136,655 0.44 3.40 2,043 464,627
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 136,655 0.44 3.40 2,043 464,627
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 135,453 0.15 3.40 673 460,540
2017-12-20 2017-12-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 135,255 -1.17 36.55 -58,480 4,943,570
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 6,281 -8.73
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 6,281 -8.73
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -198 76,152 -0.26
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 136,855 -1.01 39.75 -55,650 5,439,986
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 138,255 0.44 3.40 2,043 470,067
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 138,255 0.44 3.40 2,043 470,067
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 137,053 0.14 3.40 673 465,980
2017-11-21 2017-11-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 136,855 -1.16 39.75 -63,600 5,439,986
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 6,882 -8.03
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 6,882 -8.03
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -198 76,350 -0.26
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 138,455 -1.00 32.65 -45,710 4,520,556
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 139,855 0.43 3.40 2,043 475,507
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 139,855 0.43 3.40 2,043 475,507
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 138,653 0.14 3.40 673 471,420
2017-10-18 2017-10-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 138,455 -1.14 32.65 -52,240 4,520,556
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 7,483 -7.43
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 7,483 -7.43
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -198 76,548 -0.26
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 140,055 -0.99 30.00 -42,000 4,201,650
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 141,455 0.43 3.40 2,043 480,947
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 141,455 0.43 3.40 2,043 480,947
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 140,253 0.14 3.40 673 476,860
2017-10-02 2017-09-29 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 140,055 -1.13 30.00 -48,000 4,201,650
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 8,084 -6.92
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 8,084 -6.92
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -198 76,746 -0.26
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 141,655 -0.98 30.00 -42,000 4,249,650
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 143,055 0.42 3.40 2,043 486,387
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 143,055 0.42 3.40 2,043 486,387
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 141,853 0.14 3.40 673 482,300
2017-09-05 2017-08-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 141,655 -1.12 30.00 -48,000 4,249,650
2017-08-14 2017-08-11 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 15,000 15,000
2017-08-03 2017-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -4,062 28,438 -12.50
2017-08-03 2017-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -1,527 145,790 -1.04 25.10 -38,328 3,659,329
2017-08-03 2017-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 4,062 147,317 2.84
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 8,685 -6.47
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -601 8,685 -6.47
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -198 76,944 -0.26
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,400 143,255 -0.97 30.00 -42,000 4,297,650
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 144,655 0.42 3.40 2,043 491,827
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 601 144,655 0.42 3.40 2,043 491,827
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 198 143,453 0.14 3.40 673 487,740
2017-07-25 2017-07-21 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,600 143,255 -1.10 30.00 -48,000 4,297,650
2017-02-14 2017-01-31 5 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 658 144,855 0.46 13.73 9,034 1,988,859
2017-02-14 2016-07-31 5 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 591 144,197 0.41 15.20 8,983 2,191,794
2017-01-19 2017-01-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (right to buy)
A - Award 49,000 49,000
2017-01-19 2017-01-17 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 32,500 32,500
2016-10-03 2016-09-29 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 9,286 9,286
2016-03-14 2016-03-10 4 GBT Global Blood Therapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 9,286 9,286
2016-03-14 2016-02-01 4/A GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 749 143,606 0.52 16.09 12,051 2,310,621
2016-03-14 2015-08-17 4/A GBT Global Blood Therapeutics, Inc.
Common Stock
P - Purchase 25,000 25,000 20.00 500,000 500,000
2016-02-03 2016-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 749 168,606 0.45 16.09 12,051 2,712,871
2016-01-07 2015-08-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
P - Purchase 25,000 167,857 17.50 20.00 500,000 3,357,140
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock
285,714
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock
285,714
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)